)
Traws Pharma (TRAW) investor relations material
Traws Pharma Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Shareholders are asked to authorize a 1-for-8 to 1-for-15 reverse split, with the Board choosing the ratio and whether to implement it within 12 months after approval. The primary objective is to regain Nasdaq’s $1.00 minimum bid-price compliance.
Voting matters and shareholder proposals
Proposal 1 seeks discretionary authority for the reverse split; Proposal 2 would permit meeting adjournment to seek additional votes if needed. The Board recommends voting For both.
Each proposal requires a majority of votes cast for and against; abstentions and broker non-votes have no effect on outcomes.
The special meeting will be held virtually, with electronic voting and question submission available to participating shareholders.
Board of directors and corporate governance
The Board unanimously approved the proposed amendment on October 6, 2026, and may abandon the split or choose not to implement it even if shareholders approve.
In setting the ratio and timing, the Board plans to consider liquidity, marketability, market conditions, Nasdaq requirements, anticipated share price effects and capitalization.
- Net loss widened, cash is limited, and milestone-based financing was secured.TRAW
Q2 2026 - All proposals passed, including director elections and incentive plan changes; no questions raised.TRAW
AGM 2026 - Registering up to $139.2M in securities to fund antiviral and oncology R&D amid financial uncertainty.TRAW
Registration filing - Annual meeting seeks approval for director elections, incentive plan changes, and warrant issuances.TRAW
Proxy filing - Shareholders will vote on directors, plan amendments, auditor ratification, and warrant share issuance.TRAW
Proxy filing - Virtual meeting to vote on directors, incentive plan, auditor, share issuance, and governance.TRAW
Proxy filing - Q1 2026 net loss was $7.1M; up to $60M financing secured, but liquidity concerns persist.TRAW
Q1 2026 - Registering 35.9M shares for resale, with proceeds from warrants funding clinical development.TRAW
Registration filing - Lead antivirals progress, $20M financing, and CEO change position for 2025 milestones.TRAW
Q4 2024 & Study Update
Next Traws Pharma earnings date
Next Traws Pharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)